A Case of Type V Hyperlipoproteinemia Resistant to Insulin Treatment.

cardiovascular disease hypertriglyceridemia induced pancreatitis insulin resistance multifactorial chylomicronemia syndrome severe hypertriglyceridemia

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jul 2023
Historique:
accepted: 05 07 2023
medline: 7 8 2023
pubmed: 7 8 2023
entrez: 7 8 2023
Statut: epublish

Résumé

Type V hyperlipoproteinemia or multifactorial chylomicronemia syndrome is a rare lipid disorder triggered mainly by uncontrolled diabetes, obesity, poor diet, or particular medications. It is associated with an increased risk of acute pancreatitis and accelerated coronary artery disease which may manifest in younger age groups. We present a case of a 42-year-old male who presented to the emergency department (ED) complaining of a non-healing hand injury. Upon laboratory workup, the patient was found to have an elevated total cholesterol (TC) of 1129 mg/dL, very low levels of high-density lipoprotein (HDL) and triglycerides (TG) > 4000 mg/dL with an inability to calculate low-density lipoprotein (LDL). Lipoprotein electrophoresis revealed an actual TG level of > 7000 mg/dL, increased chylomicrons, normal B and pre-B-lipoproteins, and increased L-lipoproteins with an elevated Apolipoprotein B. Despite these derangements, the patient did not exhibit any abdominal complaints, demonstrating a normal lipase level. The physical exam was indicative of bilateral arcus senilis and obesity. Insulin drip was initiated along with intravenous (IV) hydration and it required 12 days to bring triglycerides down to less than 1000 mg/dL. The total cholesterol was also seen to be down trending to around 500 mg/dL and the HDL improved to 22 mg/dL. We present this case as a unique presentation of asymptomatic chylomicronemia resistant to insulin treatment with an elevated ApoB but with no evidence of pancreatitis or coronary artery disease.

Identifiants

pubmed: 37546045
doi: 10.7759/cureus.41424
pmc: PMC10403339
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e41424

Informations de copyright

Copyright © 2023, Mangeshkar et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Clin Lipidol. 2018 Jul - Aug;12(4):928-936
pubmed: 29685592
Expert Rev Cardiovasc Ther. 2020 Jun;18(6):355-361
pubmed: 32511037
Ann Intern Med. 2019 May 7;170(9):626-634
pubmed: 31035285
J Clin Lipidol. 2011 Jan-Feb;5(1):37-44
pubmed: 21262505
Front Cardiovasc Med. 2022 Apr 14;9:886266
pubmed: 35498015
Klin Wochenschr. 1978 May 1;56(9):457-60
pubmed: 206763
J Clin Gastroenterol. 2014 Mar;48(3):195-203
pubmed: 24172179
J Atheroscler Thromb. 2012;19(1):1-12
pubmed: 22129523
J Clin Lipidol. 2019 Jan - Feb;13(1):80-88
pubmed: 30466821
Clin Pharmacol. 2022 Jul 16;14:49-59
pubmed: 35873366
J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3473-e3482
pubmed: 34019660
J Clin Lipidol. 2012 Sep-Oct;6(5):450-61
pubmed: 23009781
Am J Cardiol. 2007 Mar 19;99(6A):22C-31C
pubmed: 17368274
Drugs. 2021 Jun;81(9):1101-1105
pubmed: 34003472
J Clin Gastroenterol. 2017 Aug;51(7):586-593
pubmed: 28682990
Circulation. 2019 Jun 18;139(25):e1046-e1081
pubmed: 30565953
Eur Heart J. 2020 Oct 21;41(40):3936-3945
pubmed: 32860031
J Clin Lipidol. 2020 Mar - Apr;14(2):201-206
pubmed: 32107181
Nutr Res. 2022 May;101:43-52
pubmed: 35367870
Atherosclerosis. 2015 Apr;239(2):483-95
pubmed: 25706066
Curr Med Res Opin. 2005 May;21(5):665-82
pubmed: 15969866
J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1332-e1342
pubmed: 33221907
Nat Rev Endocrinol. 2015 Jun;11(6):352-62
pubmed: 25732519
Front Endocrinol (Lausanne). 2020 Oct 23;11:593931
pubmed: 33193106

Auteurs

Shaunak Mangeshkar (S)

Internal Medicine, Albert Einstein College of Medicine, Jacobi Medical Center, New York, USA.

Natalia Nazarenko (N)

Internal Medicine, Albert Einstein College of Medicine, Jacobi Medical Center, New York, USA.

Dimitrios Varrias (D)

Internal Medicine, Albert Einstein College of Medicine, Jacobi Medical Center, New York, USA.

Michail Spanos (M)

Cardiovascular Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA.

Pawel Borkowski (P)

Internal Medicine, Albert Einstein College of Medicine, Jacobi Medical Center, New York, USA.

Majd Al Deen Alhuarrat (MAD)

Internal Medicine, Albert Einstein College of Medicine, Jacobi Medical Center, New York, USA.

Weijia Li (W)

Cardiology, AdventHealth Orlando, Orlando, USA.

Preeti Kishore (P)

Medicine, Jacobi Medical Center, New York, USA.

Robert T Faillace (RT)

Internal Medicine, Albert Einstein College of Medicine, Jacobi Medical Center, New York, USA.

Classifications MeSH